cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.17632/c9ft5p6yby
title: Monte Carlo simulated data for multi-criteria selection of city and compact electric vehicles in Poland

description: The data presented in this article describes a multi-criteria decision problem, where 13 criteria and 14 alternatives have been taken into account, consisting in the selection of an electric vehicle. The data set contains: (1) the parameters of the electric vehicles concerned included in the alternative performance model, (2) the weights of the criteria for assessing the vehicles, preference functions and thresholds constituting the preference model, (3) the overall performances and rankings of the alternatives (electric vehicles concerned).
DOI: 10.17632/kg4rjcnc3g
title: Schinopsis haenkeana presence in central Argentina

description: The data set "Schinopsis haenkeana presence in central Argentina" includes 2 .tif raster layers, and provides 1) binary classification of the presence of woody species Schinopsis haenkeana and 2) differentiation between forest and scrubland where it is found S. haenkeana.
DOI: 10.17632/ftcwpfhvws
title: An Ethnographic Study of Dalit Activism in Sindh (Supplementary Thesis Data)

description: Table of Contents Identity Politics in Pakistan: An Ethnographic Study of Dalit Activism in Sindh 1 Approved Application of Reservation for SCs and Age Relaxation 1 Scheduled castes Schoalrships and Quotas 2 Scholarhsips for SCs 3 Scheduled Caste Certificate 6 A sample of advertised post by Government of Sindh 7 School Leaving Certificate of a Scheduled Caste, mentioning caste and religion separately 8 Clause 3 of Article 106 as Amended in the constitution of 1973 9 List of Chief Ministers of Sindh 11 Composition of Sindh Government (2013-2017) 14 Bheel Intellectual Forum: Heartbeat of Dalit Activism in Pakistan 16 Petition, Sensi Tribes and Scheudled Tribes/Castes and religous Status 20 P L D 1993 Supreme Court 439 Present. 20 Fifth Scheduled, Government of India, Act, 1935 22 Government of India Act, 1935 22 Application form for the post of sanitary worker 27 Notification by Deputy Commissioner Sangahr for notifiying selection of minority committee 29 Major Hindu Temples of Pakistan as outlined by Pakistani Hindu Council 30 Sample of Study (Forums and Organizations) 32 Caste Structure of Sindh Assembly 35 Sindh Assembly 2002 - 2007 36 Caste elite of Sindh 37 Caste Elite of Sindh: District-wise Break-up 37 Demographics of Pakistan, Scheduled caste population 40 Harappa Ancestry Project 45
DOI: 10.6084/m9.figshare.12376538.v1
title: Cost-Effectiveness Analysis FBAT vs RBT

description: A cost-effectiveness analysis model built in @Risk add-on to excel. @Risk functions are 'swapped out' for ease of exploration<br>
DOI: 10.6084/m9.figshare.24160182.v1
title: Supplementary Material for: Clinical utility of inflammatory and nutritious index as therapeutic prediction of nivolumab plus ipilimumab in advanced NSCLC

description: Background: Biomarkers for predicting the outcome of ipilimumab plus nivolumab (Nivo-Ipi) treatment in cancer patients have not been identified. Herein, we investigated the prognostic significance of inflammatory and nutritional markers in patients with advanced non-small cell lung cancer (NSCLC) receiving Nivo-Ipi. Methods: Our study retrospectively analyzed 101 patients with advanced NSCLC who received Nivo-Ipi at a single institution. Inflammatory and nutritional indices were correlated with patient outcomes and included the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), systemic immune-inflammation index (SII), prognostic nutritional index (PNI), advanced lung cancer inflammation index (ALI), and Glasgow prognostic score (GPS). Results: The NLR significantly correlated with the PLR, SII, PNI, ALI, and GPS. Regarding therapeutic efficacy, the NLR, SII, and PNI predicted a partial response, and all indices predicted progressive disease. In subgroup analyses, the SII, PNI, and ALI predicted the outcome of patients with adenocarcinoma, whereas only the PNI predicted the outcome of patients with non-adenocarcinoma. The PNI and SII were the most useful indices in patients with a programmed death ligand-1 expression level of &lt;1% and ≥1%, respectively. Conclusion: The NLR, PLR, SII, PNI, ALI, and GPS were significantly associated with the outcome of Nivo-Ipi treatment in patients with NSCLC. The PNI was the most suitable marker regardless of histological type. The SII and PNI were the most promising markers for patients with and without PD-L1 expression, respectively.
DOI: 10.6084/m9.figshare.26502358.v1
title: Financial data

description: This data belongs to registered Pakistani companies and based on financial data.
DOI: 10.6084/m9.figshare.9117095.v11
title: secondary_structures_of_eukaryotic_group_II_introns_rfam_set(no_yadd)

description: secondary structures of eukaryotic group II introns rfam set (no yadd)
DOI: 10.6084/m9.figshare.27178728.v1
title: Species and Climate Model Data for the Manuscript "Projecting Untruncated Climate Change Effects on Species’ Climate Suitability: Insights from an Alpine Country" by Adde et al. (2024), Global Change Biology

description: This dataset (Adde_2024_GCB_data.zip) contains species occurrence and climate data used for climate suitability modelling. It includes species identifiers, conservation status in Switzerland, point classifications, and bioclimatic variables for each of the 7,291 modelled species, for inside (data_reg.csv) and outside (data_glo.csv) Switzerland. See ReadMe.txt for additional details.
DOI: 10.6084/m9.figshare.28001450.v1
title: GBM-Reservoir: Dataset and Segmentations

description: In this repository, we present a brain tumor database collection comprising 23,049 samples, with each sample including four different types of MRI brain scans: FLAIR, T1, T1ce, and T2. Additionally, two segmentation masks (ground truth) are provided for each sample. The first mask is the raw output from the registration process, while the second is a post-processed version of the first, designed to simplify interpretation and optimize it for network training. These samples have been acquired via registration process of 438 samples available at the moment of registration from the original dataset provided by the BraTS 2022 Challenge. Registering each pair of existing brain scans results in two additional scans that retain a similar brain shape while featuring varying tumor locations. Consequently, by registering all possible pairs, a dataset originally consisting of n samples can be expanded to n<sup>2</sup> samples. The original dataset was collected from different institutions under standard clinical conditions, but with different equipment and imaging protocols. As a result, the image quality is heterogeneous, reflecting the diversity of clinical practices across institutions. This dataset can be utilized for various tasks, such as developing fully automated segmentation algorithms for new, unseen brain tumor cases, particularly through deep learning-based approaches, since ground truth is provided for each sample.
DOI: 10.6084/m9.figshare.19115673.v1
title: The development of a self-management intervention for stroke survivors – My Life After Stroke (MLAS)

description: Long-term needs of stroke survivors (especially psychosocial needs and stroke prevention) are not adequately addressed. Self-management programmes exist but the optimal content and delivery approach is unclear. We aim to describe the process undertook to develop a structured self-management programme to address these unmet needs. Based on the Medical Research Council framework for complex interventions, the development involved three phases: “Exploring the idea”: Evidence synthesis and patient and public involvement (PPI) with stroke survivors, carers and healthcare professionals. “The iterative phase”: Development and iterative refinement of the format, content, underpinning theories and philosophy of the self-management programme My Life After Stroke (MLAS), with PPI. MLAS consists of two individual appointments and four group sessions over nine weeks, delivered interactively by two trained facilitators. It aims to build independence, confidence and hope and focusses on stroke prevention, maximising physical potential, social support and managing emotional responses. MLAS is grounded in the narrative approach and social learning theory. “Ready for research”: The refinement of a facilitator curriculum and participant resources to support programme delivery. Through a systematic process, we developed an evidence- and theory-based self-management programme for stroke survivors MLAS warrants evaluation in a feasibility study.Implications for rehabilitationMy Life After Stroke(MLAS) has been developed using a systematic process, to address the unmet needs of stroke survivors.This systematic process, involved utilising evidence, theories, patient and public involvement, expertise and guidelines from other long-term conditions. This may further help the development of similar self-management programme within the field of stroke.MLAS warrants further evaluation within a feasibility study. My Life After Stroke(MLAS) has been developed using a systematic process, to address the unmet needs of stroke survivors. This systematic process, involved utilising evidence, theories, patient and public involvement, expertise and guidelines from other long-term conditions. This may further help the development of similar self-management programme within the field of stroke. MLAS warrants further evaluation within a feasibility study.
DOI: 10.6084/m9.figshare.25834858.v1
title: Supplementary Material for: Clinical utility of the novel oncological criteria of resectability for advanced hepatocellular carcinoma

description: Introduction: Introduction of new systemic therapies for hepatocellular carcinoma (HCC) has led to the development of new oncological criteria of resectability for the resectability of HCC. This study was aimed at validating the prognosticating ability and clinical utility of the resectability classification based on the novel criteria in real world clinical practice. Methods: This study was conducted in 1,822 patients who had undergone curative resection for HCC (Population 1) and 107 patients with unresectable disease who had received lenvatinib therapy (Population 2). Patients were classified into three groups according to the novel oncological criteria for resectability (R, resectable; BR1, borderline resectable 1; and BR2, borderline resectable 2) and the prognosticating ability and clinical utility of this classification based on the novel criteria were examined. Results: Multivariate analysis confirmed that classification of the patients according to the oncological resectability criteria was significantly correlated with the overall survival (BR1: hazard ratio [HR], 1.88; 95% CI, 1.38-2.55; BR2: HR, 4.12; 95% CI, 3.01-5.65) and recurrence-free survival (BR1: HR, 1.86; 95% CI, 1.44-2.41; BR2: HR, 3.62; 95% CI, 2.71-4.82) in Population 1. In Population2, the resectability classification was correlated with the rates of successful additional intervention (surgery, transarterial chemoembolization, or radiotherapy) (BR1 65.7% vs. BR2 42.3%, P = 0.023) and curative-intent conversion surgery (BR1 17.1% vs. BR2 4.2%, P = 0.056) after lenvatinib therapy, and was also predictive of the overall survival (HR, 1.96; 95% CI, 1.13-3.38 for BR2 [vs. BR1]) and time-to-treatment failure (HR, 1.81; 95% CI, 1.04-3.17 for BR2 [vs. BR1]). Conclusion: The resectaility classification based on the noverl oncological criteria for resectability showed acceptable prognosticating ability in both surgically and medically treated populations with advanced HCC.
DOI: 10.6084/m9.figshare.6873863.v3
title: nv_non_nv_inceptionv3.h5

description: The NV v/s ALL classifier Keras model
DOI: 10.17632/yjjxmc443t
title: METTL3-mediated m6A methylation of lncRNA PVT1 promotes the progression of oral squamous cell carcinoma via the miR-185-5p/SERPINB4 axis.

description: METTL3-mediated m6A methylation of lncRNA PVT1 promotes the progression of oral squamous cell carcinoma via the miR-185-5p/SERPINB4 axis.
DOI: 10.6084/m9.figshare.24155160.v1
title: Supplementary Material for: Trends in accuracy and appropriateness of alopecia areata information obtained from a popular online large language model, ChatGPT

description: Patients with alopecia areata (AA) may access a wide range of sources for information about AA, including the recently developed ChatGPT. Assessing the quality of health information provided by these sources is crucial, as patients are utilizing them in increasing numbers. This study aimed to evaluate appropriateness and accuracy of responses to common patient questions about AA generated by ChatGPT. Responses generated by ChatGPT 3.5 and ChatGPT 4.0 to 25 questions addressing common patient concerns were assessed by multiple attending dermatologists in an academic center for appropriateness and accuracy. Appropriateness of responses by both models for use in two hypothetical contexts: 1) for patient-facing general information websites, and 2) for electronic health record (EHR) message drafts were measured. This study found the accuracy across all responses was 4.41 out of 5. Accuracy scores of responses ChatGPT 3.5 responses had a mean of 4.29, whereas those generated by ChatGPT 4.0 had mean accuracy score of 4.53. Assessments ranged from 100% of responses rated as appropriate for the general question category to 79% questions about management for an EHR message draft. Raters largely preferred responses generated by ChatGPT 4.0 vs. ChatGPT 3.5. Reviewer agreement was found to be moderate across all questions, with a 53.7% agreement and Fleiss’ κ co-efficient of 0.522 (p-value &lt; 0.001). The large language model ChatGPT outputted mostly appropriate information for common patient concerns. While not all responses were accurate, the trend toward improvement with newer iterations suggests potential future utility for patients and dermatologists.
DOI: 10.6084/m9.figshare.27084208.v2
title: <b>PKD2 in Ischemic Stroke</b>

description: The following documents are uploaded in figshare: Metadata with detailed information for the projectRaw Western Blotting images (wbblot1, wbblot2, wbblot3)Factual data for figures in a publication (PMID: 37730136).
DOI: 10.6084/m9.figshare.27684732.v1
title: Supplementary Table 1-6

description: Supplementary Table 1-6
DOI: 10.17632/3wv5wjk9tc
title: Repository of life tables

description: The objective is to provide readily accessible life tables for both the general population and insurer population across various countries
DOI: 10.6084/m9.figshare.28107059.v1
title: Dataset - Bias Perceptions of Generative AI: A Comparison of Public Sentiment on Twitter and Workplace Perspectives.zip

description: Dataset from <b>Bias Perceptions of Generative AI: A Comparison of Public Sentiment on Twitter and Workplace Perspectives </b>research paper
DOI: 10.6084/m9.figshare.14743086.v1
title: Supplementary Material for: Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia

description: <b><i>Introduction:</i></b> Phosphate binders are used to treat hyperphosphatemia. Some patients have inappropriately controlled serum phosphorus levels, which may occur for many reasons, including a high pill burden and adverse events (AEs). Tenapanor selectively inhibits the passive paracellular transfer of phosphate in the gastrointestinal tract, thereby reducing serum phosphorus levels. This novel mechanism of action may contribute to improved phosphate management. The efficacy and safety of tenapanor have not been evaluated in Japanese patients with high serum phosphorus levels despite treatment with phosphate binders. This study aimed to assess the efficacy and safety of add-on tenapanor therapy for reducing serum phosphorus levels in this population. <b><i>Methods:</i></b> This multicenter, double-blind, randomized, placebo-controlled trial enrolled patients with refractory hyperphosphatemia undergoing hemodialysis. Patients were randomly assigned in a 1:1 ratio to receive tenapanor or placebo as an add-on to their phosphate binder regimen for 6 weeks. Change in serum phosphorus levels at week 6 (day 43) compared with the baseline value (day 1, week 0) (primary endpoint), achievement of target serum phosphorus levels (serum phosphorus level ≤6.0 or ≤5.5 mg/dL), and safety, based on all AEs and drug-related AEs, were among the outcomes evaluated. <b><i>Results:</i></b> In total, 24 patients were randomly assigned to the placebo group and 23 to the tenapanor group. The mean serum phosphorus level decreased from 7.01 mg/dL on day 1 to 6.69 mg/dL on day 43 in the placebo group and from 6.77 mg/dL on day 1 to 4.67 mg/dL on day 43 in the tenapanor group. In the placebo and tenapanor groups (modified intent-to-treat population), the mean (standard deviation) change in the serum phosphorus level at day 43 (last observation carried forward [LOCF]) was 0.08 (1.52) mg/dL and −1.99 (1.24) mg/dL, respectively, with a between-group difference of −2.07 (95% confidence interval: −2.89, −1.26; <i>p</i> &lt; 0.001). The target achievement rate (serum phosphorus level ≤6.0 mg/dL at week 6 [LOCF]) was 37.5 and 87.0% in the placebo and tenapanor groups, respectively. Diarrhea was the most common drug-related AE, and it occurred in 8.3 and 65.2% of patients in the placebo and tenapanor groups, respectively. No specific AEs were observed with add-on tenapanor or with phosphate binders. <b><i>Discussion/Conclusion:</i></b> Therapy with existing phosphate binders and add-on tenapanor resulted in a significant decrease in serum phosphorus level compared with the placebo group in patients with refractory hyperphosphatemia despite treatment with phosphate binders. No new safety signals were raised, and add-on tenapanor was generally well tolerated.
DOI: 10.6084/m9.figshare.1608865.v1
title: Cancer of the Colon and Rectum in New York State, by ZIP code, 1993-1997

description: This is one of four collections of cancer rate maps by ZIP code in New York State published in 2000 (breast, colorectal, lung) and 2001 (prostate) by the New York State Department of Health as part of the Cancer Surveillance Improvement Initiative. At some point they were removed from the public web site and do not appear to have been otherwise archived online.
DOI: 10.6084/m9.figshare.25664898.v1
title: Data of ' Divergent roles of UV exposure and microclimatic conditions in the decomposition of standing and soil surface litter in a semi-arid steppe '

description: Data of litter decomposition field experiment. The meaning and units of variables can be found in the readme file.
DOI: 10.6084/m9.figshare.28057997.v2
title: Observed GEM and DGM data in the Arctic Ocean

description: This dataset includes the observed concentrations of both atmospheric gaseous elemental mercury and marine dissolved gaseous mercury, and the corresponding auxiliary data. This dataset was acquired in the Arctic Ocean in summertime, 2023.
DOI: 10.6084/m9.figshare.23289635.v1
title: canRcode4Graph_demo2022.R & data.

description: このサイトで使うデータとスクリプトです。 https://scrapbox.io/cannonor/基本パートのサンプルコードの使い方
DOI: 10.6084/m9.figshare.25383697.v17
title: Silicodata: An Annotated Benchmark CXR Dataset for Silicosis Detection

description: This research attempts to provide first its type public dataset for silicosis detection. The dataset contains frontal chest X-rays collected over three years. The data has been collected from the stone workers in the primary health centres of Rajasthan, India. The dataset contains samples of silicosis, STB, TB, and normal. The average size of each sample is around 3567 x 2898. The samples in the dataset are made available as three-channel JPG images. The dataset is divided into two sets:Set A: It contains images with only disease labels.Set B: It contains images with lung segmentation maps, annotations and disease labelsTo obtain access to the dataset, please email the duly filled-out license agreement to databases@iab-rubric.org with the subject line "Licence Agreement for the Silicodata Dataset.".NOTE: The license agreement has to be signed by someone having the legal authority to sign on behalf of the institute, such as the head of the institution or registrar. If a license agreement is signed by someone else, it will not be processed further.This database is available only for research and educational purposes and not for any commercial use<br>
DOI: 10.6084/m9.figshare.24030324.v1
title: netTransfer_20cat.mat

description: Trained EmoNet model, which uses AlexNet with an emotion category-specific final layer. In Matlab.https://www.science.org/doi/full/10.1126/sciadv.aaw4358<br>
DOI: 10.6084/m9.figshare.19499282.v1
title: patches and local annotations, slide 008, zoom 248x248 um2

description: patches and local annotations: data for slide with ID of the last 3 characters of the file name: local annotations in csv format and a folder with patches at zoom level indicated at the 6th character of the file name
DOI: 10.6084/m9.figshare.19673493.v1
title: Outlier diagnostics datasets

description: A sample FMRI dataset with functional runs and task files. <br> For project on automatic outlier detection.
DOI: 10.6084/m9.figshare.27144966.v1
title: Supplementary Material for: Periodic paralysis – A case series with a literature review

description: Introduction:
Periodic paralysis is a condition that causes recurrent episodes of flaccid paralysis, and it can be primary or secondary. Hypokalemic periodic paralysis is the most common type of primary periodic paralysis, and it is inherited through autosomal dominant gene transmission. Males are affected three times more often than females, and the paralysis attacks usually occur at night after a period of vigorous exercise. It is crucial to exclude other diagnostic entities based on the nature of presentation, physical examination, and paraclinical studies. Thyrotoxic periodic paralysis is more prevalent in Asian or Hispanic males with thyrotoxicosis, where up to 10% of thyrotoxic patients may experience periodic paralysis.
Case presentations:
Here we present 6 cases of patients who came to our care with varying degrees of muscle weakness, each showing interesting and diverse laboratory results.
Conclusion:
In patient assessment, it's crucial to consider social and family history. Even without this information, awareness of potential diagnoses is vital. The cause should be carefully considered for possible simple treatments. Failing to recognize and address this condition promptly could lead to severe outcomes. Timely identification and intervention are essential for effective disease management and patient welfare.
DOI: 10.6084/m9.figshare.28764716.v1
title: Numerical data used to generate figures and tables for the article “Hypoxia sensing requires H<sub>2</sub>S-dependent persulfidation of olfactory receptor 78”

description: Numerical data used to generate figures and tables for the article “Hypoxia sensing requires H<sub>2</sub>S-dependent persulfidation of olfactory receptor 78”
DOI: 10.6084/m9.figshare.28776806.v1
title: Maternal anxiety and response towards female conspecifics in Tibetan macaques: insight into female cognition on intra-sexual social relationship

description: we investigates maternal anxiety and behavioral responses in Tibetan macaques (<i>Macaca thibetana</i>) at Mt. Huangshan, China, to elucidate female cognition of intra-sexual social relationships. By analyzing self-directed behaviors (SDBs, proxy of anxiety) and retrieval responses of mothers during mother-infant separation, we examined how kinship, dominance rank, and lactation state of proximate females influenced maternal strategies.